These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 30777929

  • 1. MiR-20a-5p regulates gemcitabine chemosensitivity by targeting RRM2 in pancreatic cancer cells and serves as a predictor for gemcitabine-based chemotherapy.
    Lu H, Lu S, Yang D, Zhang L, Ye J, Li M, Hu W.
    Biosci Rep; 2019 May 31; 39(5):. PubMed ID: 30777929
    [Abstract] [Full Text] [Related]

  • 2. Differential processing of let-7a precursors influences RRM2 expression and chemosensitivity in pancreatic cancer: role of LIN-28 and SET oncoprotein.
    Bhutia YD, Hung SW, Krentz M, Patel D, Lovin D, Manoharan R, Thomson JM, Govindarajan R.
    PLoS One; 2013 May 31; 8(1):e53436. PubMed ID: 23335963
    [Abstract] [Full Text] [Related]

  • 3. miR-153 enhances the therapeutic effect of gemcitabine by targeting Snail in pancreatic cancer.
    Liu F, Liu B, Qian J, Wu G, Li J, Ma Z.
    Acta Biochim Biophys Sin (Shanghai); 2017 Jun 01; 49(6):520-529. PubMed ID: 28459992
    [Abstract] [Full Text] [Related]

  • 4. Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.
    Tu M, Li H, Lv N, Xi C, Lu Z, Wei J, Chen J, Guo F, Jiang K, Song G, Gao W, Miao Y.
    Mol Cancer; 2017 Mar 21; 16(1):66. PubMed ID: 28327155
    [Abstract] [Full Text] [Related]

  • 5. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2).
    Xia G, Wang H, Song Z, Meng Q, Huang X, Huang X.
    J Exp Clin Cancer Res; 2017 Aug 10; 36(1):107. PubMed ID: 28797284
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-20a-5p suppresses tumor angiogenesis of non-small cell lung cancer through RRM2-mediated PI3K/Akt signaling pathway.
    Han J, Hu J, Sun F, Bian H, Tang B, Fang X.
    Mol Cell Biochem; 2021 Feb 10; 476(2):689-698. PubMed ID: 33125611
    [Abstract] [Full Text] [Related]

  • 7. MiR-608 regulating the expression of ribonucleotide reductase M1 and cytidine deaminase is repressed through induced gemcitabine chemoresistance in pancreatic cancer cells.
    Rajabpour A, Afgar A, Mahmoodzadeh H, Radfar JE, Rajaei F, Teimoori-Toolabi L.
    Cancer Chemother Pharmacol; 2017 Oct 10; 80(4):765-775. PubMed ID: 28887583
    [Abstract] [Full Text] [Related]

  • 8. ARID1A promotes chemosensitivity to gemcitabine in pancreatic cancer through epigenetic silencing of RRM2.
    Li W, Chen Q, Gao W, Zeng H.
    Pharmazie; 2022 Sep 01; 77(7):224-229. PubMed ID: 36199183
    [Abstract] [Full Text] [Related]

  • 9. miRNA-93-5p Promotes Gemcitabine Resistance in Pancreatic Cancer Cells by Targeting the PTEN-Mediated PI3K/Akt Signaling Pathway.
    Wu Y, Xu W, Yang Y, Zhang Z.
    Ann Clin Lab Sci; 2021 May 01; 51(3):310-320. PubMed ID: 34162560
    [Abstract] [Full Text] [Related]

  • 10. Targeting the Warburg effect with a novel glucose transporter inhibitor to overcome gemcitabine resistance in pancreatic cancer cells.
    Lai IL, Chou CC, Lai PT, Fang CS, Shirley LA, Yan R, Mo X, Bloomston M, Kulp SK, Bekaii-Saab T, Chen CS.
    Carcinogenesis; 2014 Oct 01; 35(10):2203-13. PubMed ID: 24879635
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-101-3p reverses gemcitabine resistance by inhibition of ribonucleotide reductase M1 in pancreatic cancer.
    Fan P, Liu L, Yin Y, Zhao Z, Zhang Y, Amponsah PS, Xiao X, Bauer N, Abukiwan A, Nwaeburu CC, Gladkich J, Gao C, Schemmer P, Gross W, Herr I.
    Cancer Lett; 2016 Apr 01; 373(1):130-137. PubMed ID: 26828016
    [Abstract] [Full Text] [Related]

  • 12. RNA interference targeting the M2 subunit of ribonucleotide reductase enhances pancreatic adenocarcinoma chemosensitivity to gemcitabine.
    Duxbury MS, Ito H, Zinner MJ, Ashley SW, Whang EE.
    Oncogene; 2004 Feb 26; 23(8):1539-48. PubMed ID: 14661056
    [Abstract] [Full Text] [Related]

  • 13. miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer.
    Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E, Inazawa J.
    Sci Rep; 2017 Jun 21; 7(1):4002. PubMed ID: 28638102
    [Abstract] [Full Text] [Related]

  • 14. DSCAM-AS1 promotes tumor growth of breast cancer by reducing miR-204-5p and up-regulating RRM2.
    Liang WH, Li N, Yuan ZQ, Qian XL, Wang ZH.
    Mol Carcinog; 2019 Apr 21; 58(4):461-473. PubMed ID: 30457164
    [Abstract] [Full Text] [Related]

  • 15. Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma.
    Xie H, Lin J, Thomas DG, Jiang W, Liu X.
    Int J Clin Exp Pathol; 2012 Apr 21; 5(4):347-55. PubMed ID: 22670179
    [Abstract] [Full Text] [Related]

  • 16. miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells.
    Maftouh M, Avan A, Funel N, Frampton AE, Fiuji H, Pelliccioni S, Castellano L, Galla V, Peters GJ, Giovannetti E.
    Nucleosides Nucleotides Nucleic Acids; 2014 Apr 21; 33(4-6):384-93. PubMed ID: 24940696
    [Abstract] [Full Text] [Related]

  • 17. MiR-200c-3p and miR-485-5p overexpression elevates cisplatin sensitivity and suppresses the malignant phenotypes of non-small cell lung cancer cells through targeting RRM2.
    Liu Y, Zhang Y, Li Q, Xu R, Huang N.
    Thorac Cancer; 2022 Jul 21; 13(13):1974-1985. PubMed ID: 35599447
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-29c Increases the Chemosensitivity of Pancreatic Cancer Cells by Inhibiting USP22 Mediated Autophagy.
    Huang L, Hu C, Cao H, Wu X, Wang R, Lu H, Li H, Chen H.
    Cell Physiol Biochem; 2018 Jul 21; 47(2):747-758. PubMed ID: 29807360
    [Abstract] [Full Text] [Related]

  • 19. Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1.
    Guo K, Zheng S, Xu Y, Xu A, Chen B, Wen Y.
    Tumour Biol; 2016 Sep 21; 37(9):12843-12854. PubMed ID: 27449037
    [Abstract] [Full Text] [Related]

  • 20. Gemcitabine exhibits a suppressive effect on pancreatic cancer cell growth by regulating processing of PVT1 to miR1207.
    You L, Wang H, Yang G, Zhao F, Zhang J, Liu Z, Zhang T, Liang Z, Liu C, Zhao Y.
    Mol Oncol; 2018 Dec 21; 12(12):2147-2164. PubMed ID: 30341811
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.